510(k) Report

PMA · Approved

Approved

RX Herculink Elite Renal Stent System

P110001PMAApproved Jul 20, 2011198-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Vascular · NIN Stent, Renal

Approved on Jul 20, 2011 through premarket approval, which rests on the device’s own clinical evidence after a 198-day review.

Decided
Jul 20, 2011
Review
198 days
Class
Class III
Product code
NIN
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P110001 has 21 supplements since 2011: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2011: 22012: 72013: 12014: 12015: 12017: 12021: 42022: 12023: 12025: 2
2011high 7 (2012) · low 0 (2016)2025
View FIG. 1 as a table
YearSupplements approved
20112
20127
20131
20141
20151
20171
20214
20221
20231
20252
FIG. 1 — Supplements to P110001, 2011–2025Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NIN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All NIN devices

NIN Stent, Renal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · NIN

2in 2025

2008: 12009: 42010: 102011: 132012: 252013: 112014: 142015: 82016: 112017: 122018: 62019: 42020: 42021: 42022: 42023: 62025: 2
2007high 25 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NIN

Too few NIN 510(k)s in any year since 2007 to give a median.

Recalls per year · NIN

No recall names NIN since 2007.

Adverse event reports per year · NIN

42in 2025

2007: 82008: 102009: 112010: 42011: 212012: 382013: 452014: 282015: 702016: 342017: 612018: 1232019: 622020: 552021: 472022: 392023: 472024: 532025: 42
2007high 123 (2018) · low 4 (2010)2025

MAUDE reports naming product code NIN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—08
20081—010
20094—011
201010—04
201113—021
201225—038
201311—045
201414—028
20158—070
201611—034
201712—061
20186—0123
20194—062
20204—055
20214—047
20224—039
20236—047
20240—053
20252—042
20260—0—
Cite this page

510(k) Report. “P110001: RX Herculink Elite Renal Stent System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P110001

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026